patients who suffer from leukemia or other blood diseases, a stem cell transplant fre-quently offers the best chance of survival. Such a transplant is likely to be a life saving event. According to the Web site of the London Health Sciences Centre (2006): “Long-term survival may be greater than 80 per cent, … depending on the type of disease treated, the patient’s age, and the severity of illness. For patients with acute leukemia, long-term survival is 50–60 per cent but this is much better than 20–25 per cent survival when patients are treated with chemotherapy alone. … recipients eventually return to a normal lifestyle.” The most effective treatment for many blood diseases is radiation that destroys all blood cells in the body, both dise...
Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ALL) is one of the highest-risk AL...
Despite advances in supportive therapy to prevent complications of sickle cell disease (SCD), access...
Despite advances in supportive therapy to prevent complications of sickle cell disease (SCD), access...
For patients who suffer from leukemia or other blood diseases, a stem cell transplant frequently off...
For patients who suffer from leukemia or other blood diseases, a stem cell transplant frequently off...
Transplants of donated stem cells save the lives of many patients with blood diseases. Donation is s...
Many patients with leukemia and other blood diseases stand a good chance of recovery and a return to...
: Despite the recent dramatic progress in acute myeloid leukemia (AML) and acute lymphoblastic leuke...
Advances in Stem Cell Transplantation More Is Better, But How Much Is Enough? House Call: Save a Lif...
BACKGROUND: Allogeneic stem cell transplantation (alloSCT) reduces relapse rates in acute leukemia, ...
PREMISE: Since March 1993, 133 patients with high-risk acute leukemia (66 AML, 67 ALL) have received...
Since 75% of patients with high-risk acute leukemia do not have a human leukocyte antigen (HLA)-iden...
The number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each year cont...
Stem cell transplants have become common treatment for certain types of cancer including multiple my...
Allogeneic hematopoietic stem cell transplantation represents the only potentially curative therapeu...
Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ALL) is one of the highest-risk AL...
Despite advances in supportive therapy to prevent complications of sickle cell disease (SCD), access...
Despite advances in supportive therapy to prevent complications of sickle cell disease (SCD), access...
For patients who suffer from leukemia or other blood diseases, a stem cell transplant frequently off...
For patients who suffer from leukemia or other blood diseases, a stem cell transplant frequently off...
Transplants of donated stem cells save the lives of many patients with blood diseases. Donation is s...
Many patients with leukemia and other blood diseases stand a good chance of recovery and a return to...
: Despite the recent dramatic progress in acute myeloid leukemia (AML) and acute lymphoblastic leuke...
Advances in Stem Cell Transplantation More Is Better, But How Much Is Enough? House Call: Save a Lif...
BACKGROUND: Allogeneic stem cell transplantation (alloSCT) reduces relapse rates in acute leukemia, ...
PREMISE: Since March 1993, 133 patients with high-risk acute leukemia (66 AML, 67 ALL) have received...
Since 75% of patients with high-risk acute leukemia do not have a human leukocyte antigen (HLA)-iden...
The number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each year cont...
Stem cell transplants have become common treatment for certain types of cancer including multiple my...
Allogeneic hematopoietic stem cell transplantation represents the only potentially curative therapeu...
Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ALL) is one of the highest-risk AL...
Despite advances in supportive therapy to prevent complications of sickle cell disease (SCD), access...
Despite advances in supportive therapy to prevent complications of sickle cell disease (SCD), access...